scispace - formally typeset
A

Aihong Yang

Researcher at Tianjin University of Traditional Chinese Medicine

Publications -  19
Citations -  119

Aihong Yang is an academic researcher from Tianjin University of Traditional Chinese Medicine. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 3, co-authored 7 publications receiving 32 citations.

Papers
More filters
Journal ArticleDOI

Design, synthesis and anti-Alzheimer's disease activity study of xanthone derivatives based on multi-target strategy.

TL;DR: Kinetic analysis and molecular docking studies indicated that these xanthone derivatives targeted both the catalytically active site (CAS) and the peripheral anion site (PAS) of AChE, and all derivatives showed higher anti-oxidative activity than vitamin C.
Journal ArticleDOI

Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease

TL;DR: In this article, a series of naringenin derivatives were designed and synthesized as multifunctional anti-Alzheimer's disease (AD) agents, and the results showed that these derivatives displayed moderate-to-good acetylcholinesterase (AChE) and butyrylcholine choline (BuChE), inhibitory activities at the micromolar range (IC50, 12.91-62.52μm for AChE and 0.094-13.72-μM for BuChE).
Journal ArticleDOI

A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease.

TL;DR: In this paper, the multi-target-directed ligand (MTDL) based on "one molecule, multiple targets" has been studied to regulate multiple biological targets at the same time, which has shown higher efficacy, better safety.
Journal ArticleDOI

Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.

TL;DR: Results suggested that 1‐hydroxy‐3‐[2‐(pyrrolidin‐1‐yl)ethoxy]‐9H‐xanthen‐9‐one was promising AChEI with metal chelating ability and antioxidant ability for the further investigation.
Journal ArticleDOI

Emodin derivatives with multi-factor anti-AD activities: AChE inhibitor, anti-oxidant and metal chelator

TL;DR: Four new emodin derivatives which inhibit Alzheimer's disease were designed and the related activities such as cholinesterase inhibitor, anti-oxidant and metal chelator were evaluated, and these derivatives have multi-factor anti-Alzheimer's disease activities.